Skip to main content
OpenTrials

Clinical trial condition

Multiple Pterygium Syndrome, Autosomal Dominant

Explore clinical trials studying Multiple Pterygium Syndrome, Autosomal Dominant. Study availability and eligibility vary by location and protocol.

11 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Multiple Pterygium Syndrome, Autosomal Dominant trial results

Recruiting

HoFH, the International Clinical Collaborators Registry

NCT04815005

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +12 more
Locations
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Department of Vascular Medicine, Amsterdam UMC Amsterdam, Netherlands
  • Department of Medicine, Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, University of Cape Town Cape Town, South Africa
  • c. Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand Johannesburg, South Africa
View Trial Details
Completed

Phenotype and Etiology of Pallister-Hall Syndrome

NCT00001404

Conditions
Abnormalities, Multiple, Bone Diseases, Bone Diseases, Developmental, +28 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Greenwood Genetics Center Greenwood, South Carolina, United States
  • Ankara University School of Medicine Ankara, Turkey (Türkiye)
View Trial Details
Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT01576367

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Laken, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Le Kremlin-Bicêtre, France
View Trial Details
Completed

Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome

NCT00465985

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +18 more
Locations
  • Novartis Investigative Site San Francisco, California, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Madison, Wisconsin, United States
  • Novartis Investigative Site Le Kremlin-Bicêtre, France
View Trial Details
Completed

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT01302860

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations
  • Novartis Investigative Site Brussels, Belgium
  • Novartis Investigative Site Laken, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Le Kremlin-Bicêtre, France
View Trial Details
Completed

Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

NCT00685373

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +21 more
Locations
  • Little Rock Allergy and Asthma Clinic Little Rock, Arkansas, United States
  • UCSF School of Medicine San Francisco, California, United States
  • Allergy Center at Brookstone Columbus, Georgia, United States
  • Rush-Presbyterian St. Lukes Medical Center Chicago, Illinois, United States
View all 28 locations
View Trial Details

Related conditions